Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid β42 in mice

Brain Research

Volumn 1618, Issue , 2015, Pages 159-167

  Li, Yi Pei ^a   Yang, Guo Jun ^a   Jin, Li ^c   Yang, Hong Mei ^a   Chen, Jie ^a   Chai, Gao Shang ^b   Wang, Li ^a  

^a Henan Medical College   (China)

^b JIANGNAN UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid ; Apoptosis; Erythropoietin; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MALONALDEHYDE; PEPTIDE FRAGMENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; AVOIDANCE BEHAVIOR; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY DISORDERS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; PHOSPHORYLATION;

MUS;

AMYLOID BETA-PEPTIDES; ANIMALS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SUPEROXIDE DISMUTASE; TAU PROTEINS;

EID: 84938086696     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.05.031     Document Type: Article

References (51)

1. M.I. Assaraf, Z. Diaz, A. Liberman, W.J. Miller, Z. Arvanitakis, Y. Li, D.A. Bennett, and H.M. Schipper Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment J. Neuropathol. Exp. Neurol. 66 2007 389 398
2. R. Bernabeu, L. Bevilaqua, P. Ardenghi, E. Bromberg, P. Schmitz, M. Bianchin, I. Izquierdo, and J.H. Medina Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats Proc. Natl. Acad. Sci. USA 94 1997 7041 7046
3. M. Bobinski, J. Wegiel, M. Tarnawski, M. Bobinski, B. Reisberg, M.J. de Leon, D.C. Miller, and H.M. Wisniewski Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 414 420
4. D.J. Bonda, X. Wang, G. Perry, A. Nunomura, M. Tabaton, X. Zhu, and M.A. Smith Oxidative stress in Alzheimer disease: a possibility for prevention Neuropharmacology 59 2010 290 294
5. G.S. Chai, D.X. Duan, R.H. Ma, J.Y. Shen, H.L. Li, Z.W. Ma, Y. Luo, L. Wang, X.H. Qi, Q. Wang, J.Z. Wang, Z. Wei, D.D. Mousseau, L. Wang, and G. Liu Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid beta-peptide in rats Neurosci. Bull. 2014
6. R. Christensen, A.B. Marcussen, G. Wortwein, G.M. Knudsen, and S. Aznar Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels Exp. Neurol. 210 2008 164 171
7. A. Deshpande, E. Mina, C. Glabe, and J. Busciglio Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons J. Neurosci. 26 2006 6011 6018
8. U. Dirnagl, R.P. Simon, and J.M. Hallenbeck Ischemic tolerance and endogenous neuroprotection Trends Neurosci. 26 2003 248 254
9. L.L. Du, D.M. Chai, L.N. Zhao, X.H. Li, F.C. Zhang, H.B. Zhang, L.B. Liu, K. Wu, R. Liu, J.Z. Wang, and X.W. Zhou AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats J. Alzheimers Dis 2014
10. C.X. Gong, S. Shaikh, J.Z. Wang, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain J. Neurochem. 65 1995 732 738
11. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
12. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski, and L.I. Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc. Natl. Acad. Sci. USA 83 1986 4913 4917
13. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, and H.M. Wisniewski Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J. Biol. Chem. 261 1986 6084 6089
14. S. Hauptmann, I. Scherping, S. Drose, U. Brandt, K.L. Schulz, M. Jendrach, K. Leuner, A. Eckert, and W.E. Muller Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice Neurobiol. Aging 30 2009 1574 1586
15. T. Hutchin, and G. Cortopassi A mitochondrial DNA clone is associated with increased risk for Alzheimer disease Proc. Natl. Acad. Sci. USA 92 1995 6892 6895
16. K. Ishiguro, A. Shiratsuchi, S. Sato, A. Omori, M. Arioka, S. Kobayashi, T. Uchida, and K. Imahori Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments FEBS Lett. 325 1993 167 172
17. D. Kapogiannis, and M.P. Mattson Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease Lancet Neurol. 10 2011 187 198
18. M.D. Kaytor, and H.T. Orr The GSK3 beta signaling cascade and neurodegenerative disease Curr. Opin. Neurobiol. 12 2002 275 278
19. F. Lasne, and J. de Ceaurriz Recombinant erythropoietin in urine Nature 405 2000 635
20. M.S. Lee, S.C. Kao, C.A. Lemere, W. Xia, H.C. Tseng, Y. Zhou, R. Neve, M.K. Ahlijanian, and L.H. Tsai APP processing is regulated by cytoplasmic phosphorylation J. Cell Biol. 163 2003 83 95
21. M.L. Levy, J.L. Cummings, and R. Kahn-Rose Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease Gerontology 45 Suppl 1 1999 S15 S22
22. G. Li, R. Ma, C. Huang, Q. Tang, Q. Fu, H. Liu, B. Hu, and J. Xiang Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms Neurosci. Lett. 442 2008 143 147
23. X.C. Li, Z.F. Wang, J.X. Zhang, Q. Wang, and J.Z. Wang Effect of melatonin on calyculin A-induced tau hyperphosphorylation Eur. J. Pharmacol. 510 2005 25 30
24. X.H. Li, B.L. Lv, J.Z. Xie, J. Liu, X.W. Zhou, and J.Z. Wang AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation Neurobiol. Aging 33 2012 1400 1410
25. F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation Eur. J. Neurosci. 22 2005 1942 1950
26. F. Liu, Z. Liang, and C.X. Gong Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease Panminerva Med. 48 2006 97 108
27. G.P. Liu, Y. Zhang, X.Q. Yao, C.E. Zhang, J. Fang, Q. Wang, and J.Z. Wang Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms Neurobiol. Aging 29 2008 1348 1358
28. G.P. Liu, W. Wei, X. Zhou, H.R. Shi, X.H. Liu, G.S. Chai, X.Q. Yao, J.Y. Zhang, C.X. Peng, J. Hu, X.C. Li, Q. Wang, and J.Z. Wang Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice Mol. Ther. 21 2013 2247 2257
29. R. Liu, and J.Z. Wang Protein phosphatase 2A in Alzheimer's disease Pathophysiology 16 2009 273 277
30. R. Ma, N. Xiong, C. Huang, Q. Tang, B. Hu, J. Xiang, and G. Li Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway Neuropharmacology 56 2009 1027 1034
31. R. Ma, J. Hu, C. Huang, M. Wang, J. Xiang, and G. Li JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid beta-peptide Abeta25-35 Br. J. Pharmacol. 171 2014 3234 3245
32. D.L. McPhie, R. Coopersmith, A. Hines-Peralta, Y. Chen, K.J. Ivins, S.P. Manly, M.R. Kozlowski, K.A. Neve, and R.L. Neve DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3 J. Neurosci. 23 2003 6914 6927
33. P.I. Moreira, C. Carvalho, X. Zhu, M.A. Smith, and G. Perry Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology Biochim. Biophys. Acta 1802 2010 2 10
34. C. Mount, and C. Downton Alzheimer disease: progress or profit? Nat. Med. 12 2006 780 784
35. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767
36. J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, L.C. Kirby, P. Jouanny, B. Dubois, L. Eisner, S. Flitman, B.F. Michel, M. Boada, A. Frank, and C. Hock Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization Neurology 61 2003 46 54
37. M. Sakanaka, T.C. Wen, S. Matsuda, S. Masuda, E. Morishita, M. Nagao, and R. Sasaki In vivo evidence that erythropoietin protects neurons from ischemic damage Proc. Natl. Acad. Sci. USA 95 1998 4635 4640
38. R. Sasaki, S. Masuda, and M. Nagao Pleiotropic functions and tissue-specific expression of erythropoietin News Physiol. Sci. 16 2001 110 113
39. Y.C. Shang, Z.Z. Chong, S. Wang, and K. Maiese Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL Aging 4 2012 187 201
40. A.L. Siren, F. Knerlich, W. Poser, C.H. Gleiter, W. Bruck, and H. Ehrenreich Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain Acta Neuropathol. 101 2001 271 276
41. A.L. Siren, T. Fasshauer, C. Bartels, and H. Ehrenreich Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system Neurotherapeutics 6 2009 108 127
42. S.S. Sisodia, and G.P. St gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3 2002 281 290
43. Z.K. Sun, H.Q. Yang, J. Pan, H. Zhen, Z.Q. Wang, S.D. Chen, and J.Q. Ding Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid J. Neurosci. Res. 86 2008 3018 3027
44. A.C. van Harten, M.I. Kester, P.J. Visser, M.A. Blankenstein, Y.A. Pijnenburg, W.M. van der Flier, and P. Scheltens Tau and p-tau as CSF biomarkers in dementia: a meta-analysis Clin. Chem. Lab. Med. 49 2011 353 366
45. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration Eur. J. Neurosci. 25 2007 59 68
46. J.Z. Wang, and F. Liu Microtubule-associated protein tau in development, degeneration and protection of neurons Prog. Neurobiol. 85 2008 148 175
47. J.Z. Wang Alzheimer's disease: from molecule to clinic Neurosci. Bull. 30 2014 169 171
48. M.C. Wei, W.X. Zong, E.H. Cheng, T. Lindsten, V. Panoutsakopoulou, A.J. Ross, K.A. Roth, G.R. MacGregor, C.B. Thompson, and S.J. Korsmeyer Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death Science 292 2001 727 730
49. X. Yu, J.J. Shacka, J.B. Eells, C. Suarez-Quian, R.M. Przygodzki, B. Beleslin-Cokic, C.S. Lin, V.M. Nikodem, B. Hempstead, K.C. Flanders, F. Costantini, and C.T. Noguchi Erythropoietin receptor signalling is required for normal brain development Development 129 2002 505 516
50. C. Zhang, R.A. Rissman, and J. Feng Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model J. Alzheimers Dis. 44 2015 375 378
51. L.Q. Zhu, S.H. Wang, D. Liu, Y.Y. Yin, Q. Tian, X.C. Wang, Q. Wang, J.G. Chen, and J.Z. Wang Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments J. Neurosci. 27 2007 12211 12220